Changwei Dou

2.9k total citations
46 papers, 1.8k citations indexed

About

Changwei Dou is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Changwei Dou has authored 46 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 15 papers in Surgery and 15 papers in Oncology. Recurrent topics in Changwei Dou's work include Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers), Cancer-related molecular mechanisms research (7 papers) and Circular RNAs in diseases (6 papers). Changwei Dou is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers), Cancer-related molecular mechanisms research (7 papers) and Circular RNAs in diseases (6 papers). Changwei Dou collaborates with scholars based in China, United States and Taiwan. Changwei Dou's co-authors include Kangsheng Tu, Zhikui Liu, Yufeng Wang, Xin Zheng, Qingguang Liu, Yuli Jia, Wei Yang, Bowen Yao, Meng Xu and Liang Wang and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

Changwei Dou

45 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Changwei Dou China 22 1.2k 852 334 245 242 46 1.8k
Guang‐Zhi Jin China 25 1.2k 1.0× 733 0.9× 380 1.1× 228 0.9× 157 0.6× 48 1.7k
Oona Delpuech United Kingdom 20 1.1k 0.9× 460 0.5× 433 1.3× 243 1.0× 162 0.7× 33 1.7k
Daimin Xiang China 17 1.2k 1.0× 764 0.9× 301 0.9× 92 0.4× 123 0.5× 28 1.6k
Eunice Y. Lau Hong Kong 20 1.1k 0.9× 755 0.9× 624 1.9× 174 0.7× 139 0.6× 37 2.0k
Yufeng Wang China 28 2.0k 1.6× 1.7k 2.0× 337 1.0× 214 0.9× 115 0.5× 42 2.5k
Yongfu Zhao China 24 923 0.8× 529 0.6× 261 0.8× 158 0.6× 178 0.7× 60 1.5k
Haoming Lin China 16 1.1k 0.9× 784 0.9× 237 0.7× 513 2.1× 127 0.5× 47 1.8k
Yuezhen Deng China 20 1.1k 0.9× 646 0.8× 421 1.3× 130 0.5× 94 0.4× 34 1.8k
Géraldine Gentric France 13 951 0.8× 602 0.7× 752 2.3× 180 0.7× 195 0.8× 17 1.8k
Coral Ho United States 19 1.4k 1.1× 592 0.7× 577 1.7× 122 0.5× 288 1.2× 21 2.1k

Countries citing papers authored by Changwei Dou

Since Specialization
Citations

This map shows the geographic impact of Changwei Dou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changwei Dou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changwei Dou more than expected).

Fields of papers citing papers by Changwei Dou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changwei Dou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changwei Dou. The network helps show where Changwei Dou may publish in the future.

Co-authorship network of co-authors of Changwei Dou

This figure shows the co-authorship network connecting the top 25 collaborators of Changwei Dou. A scholar is included among the top collaborators of Changwei Dou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changwei Dou. Changwei Dou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dong, Mengmeng, Junjie Qian, Qingqing Wu, et al.. (2025). Dual enzyme-driven redox homeostasis disruption with ultrasmall Pt-decorated MoS2 for combined ferroptosis therapy of hepatocellular carcinoma. Materials Today Bio. 34. 102260–102260. 1 indexed citations
2.
Liu, Jie, Changwei Dou, Jian Chen, et al.. (2024). Evaluation of the outcomes of biliary-enteric reconstruction in robotic radical resection of hilar cholangiocarcinoma: a single-center propensity score matching analysis. Scientific Reports. 14(1). 14836–14836. 7 indexed citations
3.
Dou, Changwei, et al.. (2022). Propensity Score Analysis of Outcomes Following Laparoscopic or Open Radical Resection for Gallbladder Cancer in T2 and T3 Stages. Journal of Gastrointestinal Surgery. 26(7). 1416–1424. 10 indexed citations
4.
Wang, Zhifei, et al.. (2022). Value of 3D printing technology combined with indocyanine green fluorescent navigation in complex laparoscopic hepatectomy. PLoS ONE. 17(8). e0272815–e0272815. 11 indexed citations
5.
Dou, Changwei, Liankang Sun, Liang Wang, et al.. (2020). Bromodomain-containing protein 9 promotes the growth and metastasis of human hepatocellular carcinoma by activating the TUFT1/AKT pathway. Cell Death and Disease. 11(9). 730–730. 30 indexed citations
6.
Wang, Yuanguo, Kangsheng Tu, Donglian Liu, et al.. (2019). p300 Acetyltransferase Is a Cytoplasm‐to‐Nucleus Shuttle for SMAD2/3 and TAZ Nuclear Transport in Transforming Growth Factor β–Stimulated Hepatic Stellate Cells. Hepatology. 70(4). 1409–1423. 77 indexed citations
7.
Wei, Fangqiang, et al.. (2019). Is It Time to Consider Laparoscopic Hepatectomy for Intrahepatic Cholangiocarcinoma? A Meta-Analysis. Journal of Gastrointestinal Surgery. 24(10). 2244–2250. 17 indexed citations
8.
Wang, Cong, Changwei Dou, Yufeng Wang, et al.. (2019). TLX3 repressed SNAI1-induced epithelial-mesenchymal transition by directly constraining STAT3 phosphorylation and functionally sensitized 5-FU chemotherapy in hepatocellular carcinoma. International Journal of Biological Sciences. 15(8). 1696–1711. 9 indexed citations
9.
Xu, Qiuran, Changwei Dou, Yang Liu, et al.. (2018). Oviductus ranae protein hydrolysate (ORPH) inhibits the growth, metastasis and glycolysis of HCC by targeting miR-491-5p/PKM2 axis. Biomedicine & Pharmacotherapy. 107. 1692–1704. 35 indexed citations
10.
Dou, Changwei, Zhikui Liu, Kangsheng Tu, et al.. (2018). P300 Acetyltransferase Mediates Stiffness-Induced Activation of Hepatic Stellate Cells Into Tumor-Promoting Myofibroblasts. Gastroenterology. 154(8). 2209–2221.e14. 175 indexed citations
11.
Dou, Changwei, Zhenyu Zhou, Qiuran Xu, et al.. (2018). Hypoxia-induced TUFT1 promotes the growth and metastasis of hepatocellular carcinoma by activating the Ca2+/PI3K/AKT pathway. Oncogene. 38(8). 1239–1255. 99 indexed citations
12.
Xu, Qiuran, Jian‐Feng Tu, Changwei Dou, et al.. (2017). HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma. Molecular Cancer. 16(1). 178–178. 189 indexed citations
13.
Wang, Ruisi, Qian Ding, Thiago M. de Assuncao, et al.. (2016). Hepatic Stellate Cell Selective Disruption of Dynamin-2 GTPase Increases Murine Fibrogenesis through Up-Regulation of Sphingosine-1 Phosphate–Induced Cell Migration. American Journal Of Pathology. 187(1). 134–145. 5 indexed citations
14.
Jia, Yuli, Meng Xu, Changwei Dou, et al.. (2016). P300/CBP-associated factor (PCAF) inhibits the growth of hepatocellular carcinoma by promoting cell autophagy. Cell Death and Disease. 7(10). e2400–e2400. 37 indexed citations
15.
Tu, Kangsheng, Zhikui Liu, Bowen Yao, et al.. (2016). BCL-3 promotes the tumor growth of hepatocellular carcinoma by regulating cell proliferation and the cell cycle through cyclin D1. Oncology Reports. 35(4). 2382–2390. 21 indexed citations
16.
Dou, Changwei, Zhikui Liu, Meng Xu, et al.. (2016). miR-187-3p inhibits the metastasis and epithelial–mesenchymal transition of hepatocellular carcinoma by targeting S100A4. Cancer Letters. 381(2). 380–390. 91 indexed citations
17.
Li, Qing, et al.. (2015). Clinical Analysis of Intraperitoneal Lymphangioma. Chinese Medical Journal. 128(22). 3043–3049. 5 indexed citations
18.
Liu, Zhikui, Changwei Dou, Yuli Jia, et al.. (2015). RIG-I suppresses the migration and invasion of hepatocellular carcinoma cells by regulating MMP9. International Journal of Oncology. 46(4). 1710–1720. 27 indexed citations
19.
Dou, Changwei. (2015). Systematic review and meta-analysis of prophylactic abdominal drainage after pancreatic resection. World Journal of Gastroenterology. 21(18). 5719–5719. 13 indexed citations
20.
Liu, Zhikui, Changwei Dou, Yufeng Wang, et al.. (2015). High-mobility group box 1 has a prognostic role and contributes to epithelial mesenchymal transition in human hepatocellular carcinoma. Molecular Medicine Reports. 12(4). 5997–6004. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guang‐Zhi Jin Breakdown of academic impact, for papers by Oona Delpuech Breakdown of academic impact, for papers by Daimin Xiang Breakdown of academic impact, for papers by Eunice Y. Lau Breakdown of academic impact, for papers by Yufeng Wang Breakdown of academic impact, for papers by Yongfu Zhao Breakdown of academic impact, for papers by Haoming Lin Breakdown of academic impact, for papers by Yuezhen Deng Breakdown of academic impact, for papers by Géraldine Gentric Breakdown of academic impact, for papers by Coral Ho
Rankless by CCL
2026